Nasdaq:US$14.48 (+0.07) | HKEX:HK$23.70 (+0.60) | AIM:£2.29 (+0.02)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-05-23

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China